
Explanation:
The Price-to-Sales (P/S) ratio is the least prone to distortion or manipulation in this scenario because:
When a company aggressively capitalizes R&D expenses, it artificially inflates earnings and assets while understating expenses. Sales figures are typically less affected by such accounting manipulations, making P/S the most robust multiple in this situation.
Ultimate access to all questions.
No comments yet.